160 related articles for article (PubMed ID: 17722043)
21. Effectiveness of two-year clopidogrel + aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [two-year ClOpidOgrel need] study).
Tanzilli G; Greco C; Pelliccia F; Pasceri V; Barillà F; Paravati V; Pannitteri G; Gaudio C; Mangieri E
Am J Cardiol; 2009 Nov; 104(10):1357-61. PubMed ID: 19892050
[TBL] [Abstract][Full Text] [Related]
22. Facilitated PCI: rationale, current evidence, open questions, and future directions.
Zimarino M; Sacchetta D; Renda G; De Caterina R
J Cardiovasc Pharmacol; 2008 Jan; 51(1):3-10. PubMed ID: 18209562
[TBL] [Abstract][Full Text] [Related]
23. Thrombosis and thrombolysis: platelet membrane glycoproteins.
Skinner MP
Heart Lung Circ; 2007 Jun; 16(3):176-9. PubMed ID: 17446123
[TBL] [Abstract][Full Text] [Related]
24. Discharge antithrombotic strategies among patients with acute coronary syndrome previously on warfarin anticoagulation: physician practice in the CRUSADE registry.
Wang TY; Robinson LA; Ou FS; Roe MT; Ohman EM; Gibler WB; Smith SC; Peterson ED; Becker RC
Am Heart J; 2008 Feb; 155(2):361-8. PubMed ID: 18215609
[TBL] [Abstract][Full Text] [Related]
25. Antiplatelet therapy following drug-eluting stent implantation: new clinical data and recommendations.
Paradis JM; Ducrocq G; Tanguay JF
Minerva Cardioangiol; 2008 Feb; 56(1):139-54. PubMed ID: 18432176
[TBL] [Abstract][Full Text] [Related]
26. [Is stent thrombosis the new Achilles heel of interventional cardiology? State of the Art clinical trials, causes and approaches for prevention].
Grumann T; Diehl P; Bode C; Moser M
Hamostaseologie; 2007 Dec; 27(5):344-50. PubMed ID: 18060244
[TBL] [Abstract][Full Text] [Related]
27. Obesity and cardiovascular thrombotic events in patients undergoing percutaneous coronary intervention with drug-eluting stents.
Wang ZJ; Zhou YJ; Liu YY; Yu M; Shi DM; Zhao YX; Guo YH; Cheng WJ; Nie B; Ge HL; Jia DA; Yang SW; Yan ZX
Heart; 2009 Oct; 95(19):1587-92. PubMed ID: 19592387
[TBL] [Abstract][Full Text] [Related]
28. Emergence of the concept of platelet reactivity monitoring of response to thienopyridines.
Bonello L; De Labriolle A; Scheinowitz M; Lemesle G; Roy P; Steinberg DH; Pinto Slottow TL; Pakala R; Pichard AD; Barragan P; Camoin-Jau L; Dignat-George F; Paganelli F; Waksman R
Heart; 2009 Aug; 95(15):1214-9. PubMed ID: 19196732
[TBL] [Abstract][Full Text] [Related]
29. [The coagulation cascade--clinical implications].
Langer H; Gawaz M
Herz; 2005 May; 30(3):170-5. PubMed ID: 15902366
[TBL] [Abstract][Full Text] [Related]
30. Patients with non-ST-elevation acute coronary syndromes undergoing coronary artery bypass grafting in the modern era of antithrombotic therapy.
Chew DP; Huang Z; Pieper KS; White H; Mahaffey KW; Ferguson JJ; Califf RM; Aylward PG
Am Heart J; 2008 Feb; 155(2):239-44. PubMed ID: 18215592
[TBL] [Abstract][Full Text] [Related]
31. Safety of percutaneous coronary intervention during uninterrupted oral anticoagulant treatment.
Karjalainen PP; Vikman S; Niemelä M; Porela P; Ylitalo A; Vaittinen MA; Puurunen M; Airaksinen TJ; Nyman K; Vahlberg T; Airaksinen KE
Eur Heart J; 2008 Apr; 29(8):1001-10. PubMed ID: 18346963
[TBL] [Abstract][Full Text] [Related]
32. Elevations in soluble CD40 ligand in patients with high platelet aggregability undergoing percutaneous coronary intervention.
Obradovic SD; Antovic JP; Antonijevic NM; Ratkovic NG; Vojvodic DV; Subota VS; Gligic BLj; Obradovic DV; Marinkovic JM; Wallen HN
Blood Coagul Fibrinolysis; 2009 Jun; 20(4):283-9. PubMed ID: 19318922
[TBL] [Abstract][Full Text] [Related]
33. Predictors and impact of bleeding complications in percutaneous coronary intervention, acute coronary syndromes, and ST-segment elevation myocardial infarction.
Manoukian SV
Am J Cardiol; 2009 Sep; 104(5 Suppl):9C-15C. PubMed ID: 19695355
[TBL] [Abstract][Full Text] [Related]
34. Increased incidence of in-stent thrombosis related to cocaine use: case series and review of literature.
Singh S; Arora R; Khraisat A; Handa K; Bahekar A; Trivedi A; Khosla S
J Cardiovasc Pharmacol Ther; 2007 Dec; 12(4):298-303. PubMed ID: 18172224
[TBL] [Abstract][Full Text] [Related]
35. Role of prasugrel, a novel P2Y(12) receptor antagonist, in the management of acute coronary syndromes.
Baker WL; White CM
Am J Cardiovasc Drugs; 2009; 9(4):213-29. PubMed ID: 19655817
[TBL] [Abstract][Full Text] [Related]
36. Pharmacoinvasive management of acute coronary syndrome: incorporating the 2007 ACC/AHA guidelines: the CATH (cardiac catheterization and antithrombotic therapy in the hospital) Clinical Consensus Panel Report--III.
Cohen M; Diez JE; Levine GN; Ferguson JJ; Morrow DA; Rao SV; Zidar JP; ;
J Invasive Cardiol; 2007 Dec; 19(12):525-38; quiz 539-40. PubMed ID: 18180524
[TBL] [Abstract][Full Text] [Related]
37. Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention results of the ARMYDA-PRO (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity Predicts Outcome) study.
Patti G; Nusca A; Mangiacapra F; Gatto L; D'Ambrosio A; Di Sciascio G
J Am Coll Cardiol; 2008 Sep; 52(14):1128-33. PubMed ID: 18804738
[TBL] [Abstract][Full Text] [Related]
38. Coronary artery stents: II. Perioperative considerations and management.
Newsome LT; Weller RS; Gerancher JC; Kutcher MA; Royster RL
Anesth Analg; 2008 Aug; 107(2):570-90. PubMed ID: 18633036
[TBL] [Abstract][Full Text] [Related]
39. Revascularization in high risk patients: diabetes mellitus.
Cola C; Sabaté M
Minerva Cardioangiol; 2007 Oct; 55(5):557-77. PubMed ID: 17912163
[TBL] [Abstract][Full Text] [Related]
40. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
